The influence of the CHIEF pathway on colorectal cancer-specific mortality

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Slattery, Martha L ^a   Lundgreen, Abbie ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE; STAT PROTEIN;

ADULT; AGED; ALLELE; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; CASE CONTROL STUDY; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DUSP2 GENE; FEMALE; GENE; GENOTYPE; HUMAN; IL2RA GENE; IL6 GENE; IL8RA GENE; IL8RB GENE; INFGR1 GENE; IRF2 GENE; JAK2 GENE; MAJOR CLINICAL STUDY; MALE; MAP3K10 GENE; MMP1 GENE; NFKB1A GENE; NOS2A GENE; PHENOTYPE; PIK3CA GENE; RAF1 GENE; RECTUM CANCER; RUNX3 GENE; SCORING SYSTEM; SEPX1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD3 GENE; TLR2 GENE; TUMOR INVASION; TYK2 GENE; VDR GENE; COLON; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTUM; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECTUM; SIGNAL TRANSDUCTION;

EID: 84919910890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116169     Document Type: Article

References (54)

1. Slattery ML, Fitzpatrick FA (2009) Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila Pa) 2: 922-930.
2. Gordon KJ, Blobe GC (2008) Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 1782: 197-228.
3. Carling D (2004) Ampk. Curr Biol 14: R220.
4. Hardie DG (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179-5183.
5. Carling D (2004) The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 29: 18-24.
6. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, et al. (2003) Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 31: 216-219.
7. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235.
8. Waldner MJ, Wirtz S, Jefremow A, Warntjen M, Neufert C, et al. (2010) VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. The Journal of experimental medicine 207: 2855-2868.
9. Ono M (2008) Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99: 1501-1506.
10. Slattery ML, Wolff RK, Lundgreen A (2014) A Pathway Approach to Evaluating the Association between the CHIEF Pathway and Risk of Colorectal Cancer. Carcinogenesis.
11. Slattery ML, Potter J, Caan B, Edwards S, Coates A, et al. (1997) Energy balance and colon cancer-beyond physical activity. Cancer Res 57: 75-80.
12. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, et al. (2003) Physical activity and colorectal cancer. Am J Epidemiol 158: 214-224.
13. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al. (2005) Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129: 837-845.
14. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, et al. (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92: 1831-1836.
15. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, et al. (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10: 917-923.
16. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al. (2009) Pathway analysis by adaptive combination of P-values. Genetic epidemiology 33: 700-709.
17. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, et al. (2009) A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 52: 1304-1311.
18. Hsieh FC, Cheng G, Lin J (2005) Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun 335: 292-299.
19. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, et al. (2008) Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10: 287-297.
20. Alessi DR, Downes CP (1998) The role of PI 3-kinase in insulin action. Biochim Biophys Acta 1436: 151-164.
21. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
22. Lee DF, Hung MC (2007) All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 6: 3011-3014.
23. Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, et al. (2007) IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130: 440-455.
24. Lee SJ, Kang BW, Chae YS, Kim HJ, Park SY, et al. (2014) Genetic Variations in STK11, PRKAA1, and TSC1 Associated with Prognosis for Patients with Colorectal Cancer. Ann Surg Oncol.
25. Guervos MA, Marcos CA, Hermsen M, Nuno AS, Suarez C, et al. (2007) Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas. Cell Oncol 29: 327-334.
26. Nakanishi C, Yamaguchi T, Iijima T, Saji S, Toi M, et al. (2004) Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome. Oncology 67: 476-479.
27. Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23: 1011-1027.
28. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, et al. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19: 711-721.
29. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, et al. (2006) Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Research and Treatment 95: 65-72.
30. Zgaga L, Theodoratou E, Farrington SM, Din FV, Ooi LY, et al. (2014) Plasma Vitamin D Concentration Influences Survival Outcome After a Diagnosis of Colorectal Cancer. J Clin Oncol.
31. Fedirko V, Riboli E, Tjonneland A, Ferrari P, Olsen A, et al. (2012) Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev 21: 582-593.
32. Ditsch N, Toth B, Mayr D, Lenhard M, Gallwas J, et al. (2012) The association between vitamin D receptor expression and prolonged overall survival in breast cancer. J Histochem Cytochem 60: 121-129.
33. Slattery ML, Lundgreen A, Wolff RK (2013) VEGFA, FLT1, KDR and colorectal cancer: Assessment of disease risk, tumor molecular phenotype, and survival. Mol Carcinog.
34. Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, et al. (2004) The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Strahlenther Onkol 180: 201-208.
35. Forsti A, Li X, Wagner K, Tavelin B, Enquist K, et al. (2010) Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression. Genes Chromosomes Cancer 49: 270-281.
36. Isaksson-Mettavainio M, Palmqvist R, Forssell J, Stenling R, Oberg A (2006) SMAD4/DPC4 expression and prognosis in human colorectal cancer. Anticancer Res 26: 507-510.
37. Xie W, Rimm DL, Lin Y, Shih WJ, Reiss M (2003) Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J 9: 302-312.
38. Park J, Park E, Han SW, Im SA, Kim TY, et al. (2012) Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer. Investigational new drugs 30: 1404-1412.
39. Scharf PJ, Witney J, Daly R, Lyons BA (2004) Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain. Protein science: a publication of the Protein Society 13: 2541-2546.
40. Puri MC, Bernstein A (2003) Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America 100: 12753-12758.
41. Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, et al. (2005) A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. Journal of the National Cancer Institute 97: 975-980.
42. Tekautz TM, Zhu K, Grenet J, Kaushal D, Kidd VJ, et al. (2006) Evaluation of IFN-gamma effects on apoptosis and gene expression in neuroblastoma-preclinical studies. Biochim Biophys Acta 1763: 1000-1010.
43. Yang H, Zhou H, Feng P, Zhou X, Wen H, et al. (2010) Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 29: 92.
44. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, et al. (2006) Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15: 1126-1131.
45. Miteva LD, Stanilov NS, Deliysky TS, Stanilova SA (2014) Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression. Tumour Biol.
46. Ting WC, Chen LM, Huang LC, Hour MJ, Lan YH, et al. (2013) Impact of interleukin-10 gene polymorphisms on survival in patients with colorectal cancer. J Korean Med Sci 28: 1302-1306.
47. Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, et al. (2013) PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes & nutrition 8: 115-126.
48. Murtaugh MA, Sweeney C, Ma KN, Potter JD, Caan BJ, et al. (2006) Vitamin d receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer 55: 35-43.
49. Slattery ML, Caan BJ, Benson J, Murtaugh M (2003) Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 46: 166-171.
50. Slattery ML, Curtin K, Wolff R, Ma KN, Sweeney C, et al. (2006) PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control 17: 239-249.
51. Slattery ML, Lundgreen A, Welbourn B, Corcoran C, Wolff RK (2012) Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer. PLoS One 7: e37312.
52. Slattery ML, Lundgreen A, Welbourn B, Wolff RK, Corcoran C (2012) Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes. Mutation Research 734: 30-40.
53. Slattery ML, Murtaugh M, Caan B, Ma KN, Neuhausen S, et al. (2005) Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer 115: 148-154.
54. Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry CP Jr, et al. (1998) Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 22: 178-184.